Olaparib becomes first gene-targeted medicine to show benefits in prostate cancer 02 Dec 2019 A pioneering precision medicine already licensed for breast and ovarian cancer can also slow or stop tumour growth in some men with advanced prostate cancer, a new clinical trial shows. Find out more Show/Hide
Prostate cancer ‘super responders’ live for two years on immunotherapy 27 Nov 2019 Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown. Find out more Show/Hide
ESMO 2019: Breast and ovarian cancer drug outperforms targeted hormone therapy in some men with advanced prostate cancer 30 Sep 2019 A drug used for breast and ovarian cancer is more effective than modern targeted hormone treatments at slowing progression and improving survival in some men with advanced prostate cancer, phase III clinical trial findings reveal. Find out more Show/Hide
ESMO 2019: Modern chemotherapy drug better than second targeted hormone therapy against resistant prostate cancer 30 Sep 2019
Gene test picks out prostate cancers patients who could benefit from ‘search-and-destroy’ medicine 23 Jul 2019
ASCO 2019: Breast cancer drug effective in 80 per cent of men with BRCA-mutant prostate cancer 05 Jun 2019
Protein found more in advanced prostate cancer could be key to preventing drug resistance 08 Jan 2019